Hydroxycamptothecin Prevents Fibrotic Pathways in Fibroblasts In Vitro

Volume: 71, Issue: 5, Pages: 653 - 662
Published: Jan 28, 2019
Abstract
Peritendinous fibrosis, which leads to impaired tendon function, is a clinical problem worldwide, and it is urgent to explore potential ways to reduce the formation of peritendinous adhesion. Several studies have demonstrated the biological roles of hydroxycamptothecin (HCPT) in inhibiting fibrosis in different tissues. In this study, we investigated whether HCPT could inhibit tendon fibrosis in vitro. Our results revealed that HCPT inhibited...
Paper Details
Title
Hydroxycamptothecin Prevents Fibrotic Pathways in Fibroblasts In Vitro
Published Date
Jan 28, 2019
Journal
Volume
71
Issue
5
Pages
653 - 662
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.